showed highest degradation rate for CIP and CPD. The electrical energy consumption for both CIP and CPD, as calculated using the E EO parameter, was in the following order: UV > UV/O
INTRODUCTION
Chemicals as prescription drugs, contraceptive pills, household chemicals, detergents and cosmetics are excreted or discharged by humans as wastewater contaminants. Commonly used wastewater treatments do not sufficiently remove these contaminants, thus they may still remain in trace concentrations in the treated effluents. As a result, effluents containing micro-pollutants like pharmaceuticals enter rivers, groundwater and drinking water by direct discharge, irrigation or artificial recharge. Several studies conducted world-wide have confirmed the occurrence of pharmaceutical residues in wastewater treatment plants (WWTPs) (e.g. Hirsch et al. ) , water streams (e.g. Kolpin et al. ) , surface and ground-waters (e.g. Avisar et al. ) .
The acute and chronic effects of pharmaceutical compounds on the ecosystem and on human health are not yet fully understood, yet the problem remains worrisome, due to many concerns as the possible development of antibiotic-resistance bacteria. Other concerns rise from the presence of toxic pharmaceuticals as antineoplastic drugs that are used in cancer chemotherapy. These drugs, typically originated from hospital wastewater, even though detected in the environment at much lower concentrations in relation to other drugs, cannot be excluded as potential environmental contaminants due to their often carcinogenic and mutagenic properties (Kummerer ) .
An attractive technology for the treatment of pharmaceuticals in water is the advanced oxidation process (AOP), where pollutants are chemically oxidized by a process that produces hydroxyl (
• OH) free radicals. The hydroxyl radicals can be generated, for example, by the combined application of ozone/hydrogen peroxide 
METHODS Chemicals
Pharmaceutical standards (>99% purity) were obtained from Sigma-Aldrich, ULC grade acetonitrile and water from Bio-Lab Ltd. (Jerusalem, Israel). All chemicals were used as obtained and pharmaceutical stock solutions were prepared by dissolving the compounds in deionized water (Direct-Q3 UV system, Millipore-France) at a concentration of 100 mg/L. H 2 O 2 (30% w/w, extra pure) was obtained from Merck (Germany). Unless otherwise mentioned, all experiments were conducted in 2.5 mM phosphate buffer saline (PBS) at pH 7.
Experimental setup

UV Collimated Beam Apparatus (CBA)
A bench scale CBA was used to study the UV/H 2 O 2 process (described in details elsewhere; Lester et al. ) . In the CBA experiments, UV light is directed through a collimated tube to dose a sample solution. Experiments were carried out using a 0.45 kW medium-pressure (MP) polychromatic UV lamp emitting wavelengths at the range of 200-300 nm and beyond (Ace-Hanovia Lamp). The spectral incident irradiance obtained from a calibrated spectroradiometer (USB4000, Ocean Optics, FL, USA) was used to calculate the average irradiance and UV fluence (Bolton & Linden ). (at a range of 0.6-3.8 μM) were added separately to samples containing t-butanol (10 mM) and equal concentrations of the target and the reference compound (∼3.5 μM each). The samples were continuously mixed during the experiments and the remaining concentrations of the target and reference compounds were analyzed by HPLC/MS. The second-order rate constants with ozone were then calculated as described below (Huber et al. ):
where, k O3,CBZ (3 × 10 5 M À1 s
À1
, Huber et al. ) and k O3,C are the rate constants of O 3 with CBZ and the target compound, respectively. H represents the different applied O 3 doses.
Determination of pharmaceutical rate constants with
• OH
The second-order rate constant of the pharmaceuticals with
) was calculated in the UV/ H 2 O 2 CBA using the CK procedure (Elovitz et al. ) , where p-chlorobenzoic acid (pCBA) was used as a reference compound due to its low direct photolysis rate. In brief, a mixture of the target pollutant and reference compound (at 1 mg/L each) was exposed to UV irradiation with and without H 2 O 2 (50 mg/L). Samples were withdrawn at two minute intervals for HPLC/MS analysis. In cases where the reaction with
• OH is the only degradation process (no direct photolysis), CK was used in its simplest form (Equation (2)). However, when direct photolysis played a significant role in the pollutant's UV/H 2 O 2 degradation, a correction was made to subtract the loss of the compound due to direct photolysis (Equation (3); Elovitz et al. ).
where, k d,C is the pollutant's time-based pseudo-first-order direct photolysis rate constant (1/s), k obs,C and k obs,pCBA are the observed (total) time-based pseudo-first-order rate constants (1/s) for degradation of the target pollutant and pCBA respectively. k • OH,C and k • OH,pCBA are the secondorder rate constants of the target pollutant and pCBA with 
Analytical methods
All pharmaceuticals were detected and quantified by HPLC-UV Agilent, model 1100 (ACE-RP C18 column 2.5 mm × 250 mm) and mass spectrometer (MS) detector (Finnigan LCQ). The HPLC consists of a binary pump, microvacuum degasser, diode array detector and thermostatic column compartment. The column temperature was 32 W C, flow rate of 0.5 mL/min and injection volume of 100 μL. Positive electro-spray ionization MS mode was used where probe temperature was 220 W C. The flow from the HPLC was passed through a split connector with 60 μL/min of effluent introduced into the MS interface. Ions in the range 200-400 m/z were registered in the conventional scanning mode. For CIP and TMP, the HPLC mobile phase conditions were adapted from Lester et al. () with minor modifications. For CPD the mobile phase was ammonium formate 0.05 M (A) and methanol (B), at pH 5. The mobile phase eluent gradient started with 50% of eluent A followed by a 2.5-min linear gradient to 30% of eluent A, 3 min isocratic elution and a 2 min linear gradient back to 50% of eluent A, maintained for 4 min to equilibration time. For the detection of the CIP photo-products, irradiated samples were pre-concentrated by factor of 10 using lyophilization.
RESULTS AND DISCUSSION
Determination of pharmaceutical rate constants with O 3 and • OH The measured rate constants in the present study agree well with previously published results. The difference in rate constants between the three pharmaceuticals is due to basic structural differences. For example, the high rate constant of TMP with molecular O 3 is attributed to the presence of several amino moieties which react rapidly with O 3 (Huber et al. ) .
Pharmaceutical degradation by UV/H 2 O 2
Time based degradation of the studied pharmaceuticals by UV/H 2 O 2 using the CBA, with and without addition of 50 mg/L H 2 O 2 , is shown in Figure 1 . The fluence-based rate constants were additionally calculated to be 5.8 × 10 À3 , 3.4 × 10 À4 and 2.3 × 10 À5 cm 2 /mW for CIP, TMP and CPD respectively. Under direct UV light (no H 2 O 2 ) CIP degradation rate was highest, while CPD only slightly degraded with UV. The differences in direct photodegradation rates are due to the magnitude of the compound's molar absorption coefficients and its overlap with the emission spectra of the UV lamp, as well as differences in the compounds quantum yields.
As expected, addition of 50 mg/L H 2 O 2 to the photolysis process increased the degradation rate of all examined compounds, thus, the combined UV/H 2 O 2 process is more effective than UV alone, presumably due to
• OH radical formation. Degradation of CPD in the UV/H 2 O 2 process was previously examined by Kim et al. () . Their study showed that addition of 6 mg/L H 2 O 2 to the photolysis process in pure water (using monochromatic UV lamp at 254 nm) increased the CPD degradation rate constant by factor of 12. For comparison, in the present study, addition of 50 mg/L H 2 O 2 to the photolysis process of CPD increased its degradation rate constant by a factor of ∼90. and UV/H 2 O 2 /O 3 processes showed almost similar degradation rate, thus the addition of H 2 O 2 to the UV/O 3 process have practically no additional value on the degradation rate of CIP. Wang et al. () studied the impact of different AOPs on the degradation of three chlorophenols found in a Kraftpulp bleach plant effluent. Their study showed that degradation efficacy of each AOP was compound dependent. For example the addition of H 2 O 2 to an UV/O 3 system improved the degradation rate of 2, 3, 4, 5-Tetrachlorophenol and had no effect on the degradation of 4, 5-Dichloroguaiacol. Kusic et al. () 
Electrical energy efficiency
The electrical-energy per order parameter (E EO ) was determined, as the studied degradation processes are electrical energy related processes. The E EO parameter corresponds to the amount of electrical energy (kWh) required to reduce one order of magnitude (90% removal of contaminant) in a treated volume of contaminated water (Bolton et al. ) .
where, P is the rated power of the system (kW), V is the total volume of water treated (m 3 ) and k app is the time-based degradation rate constant of the examined compound (1/min). The rated power was calculated as the sum of the UV lamp power (0.45 kW), the O 3 production power and the energy cost of H 2 O 2 . Where, the O 3 production power 
Photo-degradation intermediates analysis
The formation of intermediate byproducts, following the degradation of an organic pollutant by UV or O 3 based processes, is one of the most important issues in the field of pharmaceutical removal. Active degradation intermediates may occasionally be formed, in particular if the active part of the molecule remains unmodified. The importance of this topic is demonstrated in Table 4 , where 12 byproducts, identified during direct UV photolysis of CIP, are presented. The moieties which are involved in the CIP photo-degradation are the piperazine residue, the carboxylic group and the fluorine atom. The quinolone skeleton however remains unchanged. The piperazine ring is either subjected to breakdown (intermediates 1-2, 4-5 and 8-12) or is epoxidized at positions 2, 3 (of the piperazine). Decarboxylation occurs at position 3 of the quinolone skeleton (intermediate 7). The fluorine at position 6 is either substituted by hydroxyl group (intermediate 3) or by hydrogen atom (intermediates 1, 2, 4, 5 and 12). In light of the fact that the characteristic quinolone is believed to be responsible for the CIP antimicrobial activity (Dodd et al. ) , intermediates which merely involve modification of the piperazine residue may still potentially exhibit antibacterial potencies. Various researchers have already identified the formation different byproducts as a result of CIP photo-degradation (e.g. Vasconcelos et al. a) .
CONCLUSIONS
AOPs which combine UV photolysis, hydrogen peroxide and ozone may present an attractive treatment for the degradation of a wide range of pharmaceuticals in water. Out of the examined processes, O 3 had the highest degradation rate for TMP and H 2 O 2 /O 3 showed highest degradation rate for CIP and CPD. H 2 O 2 concentration was found to be an important parameter in the UV/H 2 O 2 and H 2 O 2 /O 3 sub-processes, acting as an
• OH initiator at low concentrations and as an • OH radical scavenger at higher concentrations. The electrical energy consumption, as calculated using the E EO parameter, showed that O 3 based processes were more efficient than UV based processes, where O 3 was the most efficient process for the degradation of TMP, and H 2 O 2 /O 3 was the most efficient process for the degradation of CIP and CPD. Twelve degradation byproducts were identified following direct UV photolysis of CIP. Future research will investigate the formation of degradation byproducts for CIP, CPD and TMP under the different AOP conditions and evaluate their potential toxicity.
